HRT FINANCIAL LP

Position in OCUL — Ocular Therapeutix, Inc

CIK 1475597 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,577,023

+$4,569,947 QoQ

Shares Held

1,077,090

+51.9% QoQ

Ownership

0.490%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#32

of 257 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,593,086 across 183 Biotechnology names. OCUL ranks #24 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,577,023	1,077,090	+51.9%	Shares	Defined	2026-08-14
2026-03-31	$6,007,076	709,218	+76.0%	Shares	Defined	2026-05-14
2025-12-31	$4,891,970	402,963	+24.8%	Shares	Defined	2026-02-12
2025-09-30	$3,774,864	322,914	+494.0%	Shares	Defined	2025-11-14
2023-06-30	$280,497	54,360	+400.2%	Shares	Defined	2023-08-11
2022-09-30	$45,102	10,868	+4.8%	Shares	Defined	2022-11-14
2022-03-31	$51,331	10,370	-85.5%	Shares	Defined	2022-05-16
2021-09-30	$717,360	71,736	+77.5%	Shares	Defined	2021-11-15
2021-06-30	$572,942	40,405	+261.9%	Shares	Defined	2021-08-16
2020-09-30	$84,965	11,165	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.